Up to date suggestions for antiretroviral nonoccupational postexposure prophylaxis (nPEP) for HIV have been revealed within the Could 8 situation of the U.S. Facilities for Illness Management and Prevention Morbidity and Mortality Weekly Report.
Mary R. Tanner, M.D., from the CDC in Atlanta, and colleagues up to date the 2016 nPEP pointers and concerns to be used in the USA, together with concerns for testing and nPEP regimens for individuals uncovered who’ve acquired long-acting injectable antiretroviral brokers prior to now.
The authors notice that for many adults and adolescents, the popular regimens are bictegravir/emtricitabine/tenofovir alafenamide or dolutegravir plus (tenofovir alafenamide or tenofovir disoproxil fumarate) plus (emtricitabine or lamivudine). The regimens will be tailor-made to particular scientific circumstances. For individuals prescribed nPEP, medical follow-up must also be tailor-made to the scientific state of affairs; beneficial follow-up features a distant or in-person go to with a medical supplier at 24 hours and scientific follow-up at 4 to 6 and 12 weeks after publicity for laboratory testing. Individuals initiating nPEP must be knowledgeable that preexposure prophylaxis (PrEP) can scale back their threat for buying HIV within the case of repeat or persevering with publicity after the nPEP course. PrEP choices must be supplied to these with ongoing indications, and an nPEP-to-PrEP transition plan must be created.
“Communication and education strategies are needed to increase both provider and community awareness of nPEP,” the authors write.
Extra data:
Mary R. Tanner et al, Antiretroviral Postexposure Prophylaxis After Sexual, Injection Drug Use, or Different Nonoccupational Publicity to HIV — CDC Suggestions, United States, 2025, MMWR. Suggestions and Reviews (2025). DOI: 10.15585/mmwr.rr7401a1
Quotation:
Tips up to date for nonoccupational postexposure prophylaxis for HIV (2025, Could 9)
retrieved 10 Could 2025
from https://medicalxpress.com/information/2025-05-guidelines-nonoccupational-postexposure-prophylaxis-hiv.html
This doc is topic to copyright. Other than any truthful dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is offered for data functions solely.